California lawmakers have passed a psychedelics decriminalization bill and Governor Gavin Newsom will probably sign it. The money race is on. Read More
Marijuana Investing
A new report reveals a dichotomy in choices between those who are veteran purchasers of cannabis, and the newbies to the market. Read More
Psychedelics once demonized by polite society are now being deployed by the government and medical establishment to combat tobacco addiction. Read More
Health and Human Services announced this week that it’s asking the Drug Enforcement Administration to move cannabis from Schedule I to Schedule III. Read More
Instead of the multi-billion-dollar deals that grabbed headlines in the past, we’ll see a slew of smaller transactions in coming months. Read More
Consumption rates among Americans of marijuana and hallucinogenic substances are at historic levels. Investors are taking notice. Read More
New research shows that psilocybin can be more effective and less expensive than conventional drug therapies for severe depression. Read More
The German government approved legislation this week that would allow adults to buy and possess recreational cannabis. The stakes are huge. Read More
It may be the dog days of August, but legal, regulatory, and political trends that affect the worldwide cannabis sector continue apace. Read More
We address reader inquiries, with answers of universal applicability for all types of investors in the marijuana market. Read More